News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
689,749 Results
Type
Article (39229)
Company Profile (282)
Press Release (650238)
Section
Business (203944)
Career Advice (1999)
Deals (35386)
Drug Delivery (89)
Drug Development (80884)
Employer Resources (168)
FDA (16112)
Job Trends (14814)
News (344726)
Policy (32455)
Tag
Academia (2530)
Alliances (49254)
Alzheimer's disease (1288)
Approvals (16078)
Artificial intelligence (160)
Bankruptcy (354)
Best Places to Work (11600)
Biotechnology (199)
Breast cancer (204)
Cancer (1518)
Cardiovascular disease (121)
Career advice (1665)
CAR-T (106)
Cell therapy (310)
Clinical research (64915)
Collaboration (563)
Compensation (307)
COVID-19 (2549)
C-suite (133)
Data (1467)
Diabetes (186)
Diagnostics (6194)
Earnings (85021)
Employer resources (146)
Events (110343)
Executive appointments (473)
FDA (16881)
Funding (510)
Gene therapy (214)
GLP-1 (619)
Government (4338)
Healthcare (18738)
Infectious disease (2646)
Inflammatory bowel disease (114)
Interviews (309)
IPO (16388)
Job creations (3625)
Job search strategy (1418)
Layoffs (424)
Legal (7869)
Lung cancer (225)
Manufacturing (214)
Medical device (13231)
Medtech (13236)
Mergers & acquisitions (19255)
Metabolic disorders (490)
Neuroscience (1648)
NextGen: Class of 2025 (6506)
Non-profit (4471)
Northern California (1859)
Obesity (280)
Opinion (186)
Patents (133)
People (56625)
Phase I (20202)
Phase II (28586)
Phase III (21303)
Pipeline (612)
Postmarket research (2561)
Preclinical (8554)
Radiopharmaceuticals (239)
Rare diseases (284)
Real estate (5893)
Regulatory (21783)
Research institute (2312)
Resumes & cover letters (349)
Southern California (1606)
Startups (3565)
United States (16533)
Vaccines (577)
Weight loss (194)
Date
Today (36)
Last 7 days (385)
Last 30 days (1857)
Last 365 days (34829)
2025 (1604)
2024 (35252)
2023 (40077)
2022 (51173)
2021 (55710)
2020 (54086)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (203)
Asia (37390)
Australia (6104)
California (4216)
Canada (1549)
China (361)
Colorado (189)
Connecticut (203)
Europe (80052)
Florida (596)
Georgia (146)
Illinois (412)
Indiana (239)
Maryland (679)
Massachusetts (3262)
Michigan (182)
Minnesota (314)
New Jersey (1178)
New York (1197)
North Carolina (779)
Northern California (1859)
Ohio (152)
Pennsylvania (994)
South America (1093)
Southern California (1606)
Texas (609)
Utah (119)
Washington State (427)
689,749 Results for "morphimmune inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Immunome and Morphimmune Announce Successful Completion of Merger with $125 Million PIPE to Develop Novel Targeted Cancer Therapies
Immunome, Inc., a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced that it has completed its previously announced merger with Morphimmune.
October 3, 2023
·
5 min read
Deals
Immunome and Morphimmune Announce Definitive Merger Agreement and Simultaneous Private Placement Investment of $125 Million to Develop Targeted Cancer Therapies
Immunome and Morphimmune, a private biotechnology company focused on developing targeted oncology therapeutics, announced that they have entered into a definitive merger agreement.
June 29, 2023
·
15 min read
Business
MorphImmune, Inc., a Research Bridge Partners Portfolio Company, Appoints Ronald Martell as President and CEO
MorphImmune, Inc. announced the appointment of Ronald Martell as the company’s President and CEO effective April 12, 2021.
June 8, 2021
·
5 min read
Press Releases
DiFusion Inc., Announces New Patent
January 14, 2025
·
1 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Press Releases
Univec, Inc. Welcomes Michael Knight to Board of Directors
January 17, 2025
·
1 min read
Press Releases
Hologic Completes Acquisition of Gynesonics, Inc.
January 7, 2025
·
4 min read
Press Releases
GSK Enters Agreement to Acquire IDRx, Inc.
January 13, 2025
·
8 min read
Press Releases
LPOXY Therapeutics, Inc. Acquires Key Assets from Xeno Biosciences Inc. to Advance C. difficile Prevention Therapy
January 6, 2025
·
3 min read
Press Releases
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
December 20, 2024
·
2 min read
1 of 68,975
Next
